Tranexamic acid to reduce bleeding during aquablation for enlarged prostate
Treatments studied
Part of Kidney & urinary clinical trials.
This study tests whether giving a medicine called tranexamic acid before Aquablation surgery helps reduce bleeding during the procedure. The goal is to see if it makes the surgery safer and reduces blood loss for men with an enlarged prostate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 45 or older.
- You have an enlarged prostate (BPH) and are scheduled for a waterjet procedure called Aquablation.
- You do not have a history of blood clots or high risk for them.
- You do not have heart disease or a brain condition like a previous stroke.
- Your kidneys are working normally.
- You are not taking blood thinners, and have not used aspirin or warfarin recently.
- You do not have any bleeding or clotting disorder, and you do not have prostate cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called tranexamic acid, given during surgery to remove part of the prostate, can reduce bleeding. If you are scheduled for this type of prostate surgery, this treatment might help make the procedure safer and improve recovery.
This study tests whether a medicine called tranexamic acid (TXA) can reduce bleeding during urethroplasty surgery. If it works, it may help you recover with fewer complications.
This trial studies how well Aquablation works for men with an enlarged prostate (BPH) in Canada. You may be eligible if your clinician believes Aquablation is an appropriate treatment and you can complete the study visits and questionnaires.
This study is a registry that collects information from men who have had or will have a procedure called Aquablation to treat an enlarged prostate. It helps doctors learn more about how well the treatment works in real life.
This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.
This trial studies whether giving tranexamic acid (a medicine that helps reduce bleeding) during planned lower-back decompression surgery can lower blood loss or related complications. It compares patients who receive the infusion during surgery to those who meet study procedures and safety requirements.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.